Nils Schlimmer

631 total citations
9 papers, 475 citations indexed

About

Nils Schlimmer is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Nils Schlimmer has authored 9 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pharmacology. Recurrent topics in Nils Schlimmer's work include Sexual function and dysfunction studies (7 papers), Hormonal and reproductive studies (6 papers) and Pharmacology and Obesity Treatment (5 papers). Nils Schlimmer is often cited by papers focused on Sexual function and dysfunction studies (7 papers), Hormonal and reproductive studies (6 papers) and Pharmacology and Obesity Treatment (5 papers). Nils Schlimmer collaborates with scholars based in Germany, United Kingdom and Poland. Nils Schlimmer's co-authors include Magnus Baumhäkel, Michael Böhm, Ulrich Laufs, Florian Custodis, Franka List, Christoph Gensch, Mario Kratz, Graham Jackson, M Böhm and Kansu Büyükafşar and has published in prestigious journals such as Circulation, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Nils Schlimmer

9 papers receiving 461 citations

Peers

Nils Schlimmer
Hemant Solomon United States
Ganesan Adaikan Singapore
S Rastogi United States
Yian Chen China
Mary Lee United States
Debra A. Ryan United States
Hemant Solomon United States
Nils Schlimmer
Citations per year, relative to Nils Schlimmer Nils Schlimmer (= 1×) peers Hemant Solomon

Countries citing papers authored by Nils Schlimmer

Since Specialization
Citations

This map shows the geographic impact of Nils Schlimmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Schlimmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Schlimmer more than expected).

Fields of papers citing papers by Nils Schlimmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Schlimmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Schlimmer. The network helps show where Nils Schlimmer may publish in the future.

Co-authorship network of co-authors of Nils Schlimmer

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Schlimmer. A scholar is included among the top collaborators of Nils Schlimmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Schlimmer. Nils Schlimmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Baumhäkel, Magnus, et al.. (2011). Cardiovascular risk, drugs and erectile function - a systematic analysis. International Journal of Clinical Practice. 65(3). 289–298. 84 indexed citations
2.
Schlimmer, Nils, Mario Kratz, Michael Böhm, & Magnus Baumhäkel. (2011). Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol‐induced atherosclerosis. British Journal of Pharmacology. 163(4). 804–814. 26 indexed citations
3.
Baumhäkel, Magnus, Florian Custodis, Nils Schlimmer, Ulrich Laufs, & Michael Böhm. (2010). Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. Atherosclerosis. 212(1). 55–62. 31 indexed citations
4.
Baumhäkel, Magnus, Nils Schlimmer, Mario Kratz, & Michael Böhm. (2009). Erektile Dysfunktion: Indikator für Endorganschädigung beim kardiovaskulären Patienten. Medizinische Klinik. 104(4). 309–313. 4 indexed citations
5.
Baumhäkel, Magnus, Florian Custodis, Nils Schlimmer, Ulrich Laufs, & Michael Böhm. (2008). Improvement of Endothelial Function of the Corpus Cavernosum in Apolipoprotein E Knockout Mice Treated with Irbesartan. Journal of Pharmacology and Experimental Therapeutics. 327(3). 692–698. 30 indexed citations
6.
Baumhäkel, Magnus, et al.. (2008). Nebivolol, but Not Metoprolol, Improves Endothelial Function of the Corpus Cavernosum in Apolipoprotein E-Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 325(3). 818–823. 37 indexed citations
7.
Custodis, Florian, Nils Schlimmer, Franka List, et al.. (2008). Abstract 1738: The I( f )-inhibitor Ivabradine Exerts Vascular Anti-oxidative And Anti-inflammatory Effects Selectively Mediated By Reduction Of Heart Rate. Circulation. 118(suppl_18). 1 indexed citations
8.
Custodis, Florian, Magnus Baumhäkel, Nils Schlimmer, et al.. (2008). Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice. Circulation. 117(18). 2377–2387. 212 indexed citations
9.
Baumhäkel, Magnus, et al.. (2008). Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. International Journal of Impotence Research. 20(5). 493–500. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026